13D/13G Filings - BICYCLE THERAPEUTICS PLC (BCYC)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-20
4:05 pm
Purchase
2024-12-1313GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.4,230,302
8.900%
3,209,134increase
(+314.26%)
Filing
History
2024-12-19
3:47 pm
Purchase
2024-11-2113GBicycle Therapeutics plc
BCYC
Forbion Growth Opportunities Fund II Cooperatief U.A.3,452,330
7.300%
3,452,330increase
(New Position)
Filing
History
2024-12-17
6:46 pm
Purchase
2024-12-1313DBicycle Therapeutics plc
BCYC
BAKER BROS. ADVISORS LP10,885,357
22.900%
1,485,397increase
(+15.80%)
Filing
History
2024-11-14
5:46 pm
Unchanged
2024-09-3013GBicycle Therapeutics plc
BCYC
RA CAPITAL MANAGEMENT L.P.2,253,000
4.700%
0
(Unchanged)
Filing
History
2024-11-14
4:32 pm
Sale
2024-09-3013GBicycle Therapeutics plc
BCYC
Paradigm Biocapital Advisors LP0
0.000%
-3,707,001decrease
(Position Closed)
Filing
History
2024-11-13
9:30 pm
Sale
2024-09-3013GBicycle Therapeutics plc
BCYC
Jefferies Financial Group Inc.
JEF
0
0.000%
-1,948,000decrease
(Position Closed)
Filing
History
2024-06-07
4:18 pm
Purchase
2024-05-2813GBicycle Therapeutics plc
BCYC
RA CAPITAL MANAGEMENT L.P.2,253,000
5.000%
2,253,000increase
(New Position)
Filing
History
2024-05-28
4:16 pm
Purchase
2024-05-2313DBicycle Therapeutics plc
BCYC
BAKER BROS. ADVISORS LP9,399,960
19.900%
1,710,717increase
(+22.25%)
Filing
History
2024-04-18
07:29 am
Purchase
2024-04-1613DBicycle Therapeutics plc
BCYC
BAKER BROS. ADVISORS LP7,689,243
19.900%
2,865,645increase
(+59.41%)
Filing
History
2024-02-14
4:08 pm
Sale
2023-12-3113GBicycle Therapeutics plc
BCYC
Ridgeback Capital Investments L.P.844,235
2.200%
-1,420,566decrease
(-62.72%)
Filing
History
2024-02-14
4:08 pm
Purchase
2023-12-3113GBicycle Therapeutics plc
BCYC
Paradigm Biocapital Advisors LP3,707,001
9.800%
2,096,336increase
(+130.15%)
Filing
History
2024-02-14
4:07 pm
Purchase
2023-12-3113GBicycle Therapeutics plc
BCYC
Jefferies Financial Group Inc.
JEF
1,948,000
5.165%
1,948,000increase
(New Position)
Filing
History
2024-02-14
08:37 am
Purchase
2023-12-3113GBicycle Therapeutics plc
BCYC
Deep Track Capital, LP3,490,506
9.250%
671,461increase
(+23.82%)
Filing
History
2024-02-12
4:10 pm
Purchase
2024-01-3113GBicycle Therapeutics plc
BCYC
BAKER BROS. ADVISORS LP4,823,598
12.800%
4,823,598increase
(New Position)
Filing
History
2024-02-12
11:59 am
Sale
2023-12-3113GBicycle Therapeutics plc
BCYC
JANUS HENDERSON GROUP PLC
JHG
0
0.000%
-1,503,447decrease
(Position Closed)
Filing
History
2023-07-19
6:29 pm
Unchanged
2023-07-1713DBicycle Therapeutics plc
BCYC
GSK plc1,529,561
4.400%
0
(Unchanged)
Filing
History
2023-02-24
4:54 pm
Purchase
2023-02-1413GBicycle Therapeutics plc
BCYC
Paradigm Biocapital Advisors LP1,610,665
5.400%
1,610,665increase
(New Position)
Filing
History
2023-02-14
4:09 pm
Sale
2022-12-3113GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,021,168
3.400%
-551,655decrease
(-35.07%)
Filing
History
2023-02-14
4:07 pm
Sale
2022-12-3113GBicycle Therapeutics plc
BCYC
Logos Global Management LP1,435,000
4.800%
-115,000decrease
(-7.42%)
Filing
History
2023-02-14
4:06 pm
Unchanged
2022-12-3113GBicycle Therapeutics plc
BCYC
Ridgeback Capital Investments L.P.2,264,801
7.600%
0
(Unchanged)
Filing
History
Goto 0, 1, 2, Next